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ABSTRACT   Although fluoroquinolone (FQ) has been used for the treatment of various 
bacterial infectious diseases, its continued use has been problematic given the appearance 
of FQ-resistant bacteria. However, the recent discovery of four plasmid-mediated quinolone 
resistance (PMQR) genes comprising qnr1）, aac(6’)Ib-cr 2）, qepA3） and OqxAB4） since 19985） has 
provided insights in the area of FQ-resistance. For practical detection of qepA in microbiology 
laboratory, a specific, simple, rapid and cost-effective isothermal amplification method 
designated as LAMP is the good candidate to use. In this study, the development of a new 
detection method using LAMP to identify qepA1, one variant of the qepA gene, was tried. As 
the results, the LAMP method using a qepA1-specific LAMP primer set comprising five primers 
could detect all four qepA1-positive strains in addition to 17 qepA1-negative strains. The LAMP 
method is clearly much more advantageous for use in clinical laboratories. Furthermore, the 
time and accuracy benefits allow for the selection of antibiotics in a clinical setting.
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〈Regular Article〉
INTRODUCTION
   Although fluoroquinolone (FQ) has been used 
for the treatment of various bacterial infectious 
diseases, its continued use has been problematic 
given the appearance of FQ-resistant bacteria. The 
bacterial genes targeted by FQ are DNA gyrase, 
comprising the two genes gyrA and gyrB, and 
DNA topoisomerase IV, formed by the two genes 
parC and pare. FQ-resistance mainly results from 
genetic mutations in the quinolone resistance-
determining region (QRDR) located within the 
DNA topoisomerase gene of bacteria.
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   However, the recent discovery of four plasmid-
mediated quinolone resistance (PMQR) genes 
comprising qnr１）, aac(6’)Ib-cr２）, qepA３） and 
OqxAB４） since 1998５） has provided insights in 
the area of FQ-resistance. Of these four PMQR 
genes, qepA encodes a major facilitator superfamily 
(MFS)-type efflux pump which imparts resistance 
against hydrophilic FQs such as ciprofloxacin, 
norfloxacin and enroflaxin. Additionally, there are 
two variants of the qepA gene designated qepA1 and 
qepA2, and are referred to as the major and minor 
variants, respectively. There is only a two-amino 
acid difference between these variants, and both 
variants were identified from Escherichia coli ３，６）.
   Although the contribution of mutations in PMQR 
genes towards FQ-resistance is relatively low, 
changes to PMQR genes may contribute towards 
the genetic mutation of QRDRs７）, such as the 
acquisition of additional mutations. Thus, the ability 
to determine whether clinically isolated bacteria 
possess mutations in qepA in the microbiology 
laboratory is very important. Although molecular 
methods such as PCR or real-time PCR have been 
employed to detect mutations in the qepA gene８，９）, 
these methods require specialized equipment. 
To overcome this limitation, the loop-mediated 
isothermal amplification (LAMP) method was 
developed. LAMP comprises a strand displacement 
reaction using four different primers specifically 
designed to recognize six distinct regions on the 
target gene at a constant temperature10，11）.
   Briefly, LAMP is a specific, simple, rapid and 
cost-effective isothermal amplification method. 
LAMP employs Bacillus stearothermophilus (Bst) I 
DNA polymerase, and relies on auto-cycling strand 
DNA synthesis performed at 60-65℃ for 45-60 min. 
Since its development, LAMP has been widely used 
to detect various microorganisms, such as dengue 
virus, West Nile virus, and others. A schematic 
showing the construction of LAMP primers is 
shown in Fig. 1. Details of amplifications can be 
seen in previous report11）.
   In this study, the development of a new detection 
method using LAMP to identify qepA1, one variant 
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Fig. 1. Schematic presentation of LAMP primer sets including forward and backward inner, outer and loop primers around target 
DNA (modified from a Figure in reference #11).
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of the qepA gene, is described.
MATERIALS AND METHODS
   The bacterial strains used in this study are listed 
in Table 1. For LAMP to detect epA1, five LAMP 
primers were designed as shown in Table 2 by using 
the software “Primer Explore version 3” (now, it 
is upgraded to version 4; http://primerexplorer.
jp/e/). Genomic DNA from bacterial strains and 
plasmid for the qepA1 positive control (pSTVqepA) 
were extracted using the Qiagen genomic tip 20/G 
(Qiagen, Tokyo, Japan) and a Wizard plus minipreps 
DNA purification system (Promega, Tokyo, Japan), 
respectively. The LAMP reaction was performed 
using the Loopamp DNA amplification kit (Eiken 
Chemical Co. Ltd., Tokyo, Japan), according to 
the manufacturer’s instructions. A 25μl reaction 
mixture containing 40 pmol of QEP-FIP (forward 
inner primer) and QEP-BIP (backward inner primer) 
primers, 10 pmol of QEP-F3 (forward outer primer) 
and QEP-B3 (backward outer primer) primers, 
20 pmol of QEP-LF (forward loop primer), 2 x 
reaction mixture (25μl), Bst DNA polymerase 
(1μl), and 5μl of template DNA were used for 
LAMP amplification. The difference of this reaction 
compared with Fig. 1 was no usage of BIP (as 
shown in Fig. 1) primer for enhancement of PCR 
efficacy, because of no adequate sequence in the 
target gene.
   In an effort to determine the lowest detection 
limit of template copy number within the reaction, 
DNA derived from template plasmid pSTVqepA 
was employed in the LAMP method with 0.5 to 
500 copies (10-fold dilutions) in the reaction. 
LAMP amplification was confirmed by monitoring 
the increase in turbidity using LA-320C (Eiken 
Table 1. Strains used in this study and results obtained by the LAMP method
Type of gene* Strain Result
qepA1  
qnrA type
qnrB type
qnrS type
aac(6’)Ib-cr 
Escherichia coli C316 
Escherichia coli MRY04-1060
Escherichia coli MRY07-551
Escherichia coli MRY06-100
Enterobacter cloacae MRY04-769
Enterobacter cloacae MRY04-1155 
Escherichia coli ARS66 
Klebsiella oxytoca MRY04-725
Enterobacter cloacae MRY04-269 
Enterobacter cloacae MRY04-634
Escherichia coli MRY17-739, EE36 
Escherichia coli EE36
Klebsiella pneumoniae MRY05-548 
Klebsiella pneumoniae MRY05-478
Enterobacter cloacae MRY04-1272
Klebsiella pneumoniae NCB03-81, MRY05-2 
Klebsiella pneumoniae MRY05-2
Escherichia coli MRY05-244 
Escherichia coli MRY07-128
Klebsiella pneumoniae MRY05-512
Klebsiella pneumoniae MRY09-945
+
+
+
+
－
－
－
－
－
－
－
－
－
－
－
－
－
－
－
－
－
*Each genotype was characterized by PCR.
Table 2. LAMP primers utilized for the detection of qepA1
Primer Sequence (5’-3’)
QEP-F3
QEP-B3
QEP-FIP
QEP-BIP
QEP-LF
TGCCGTGCCTGGTCTAC
AGGCGAATGCGAAGAACG
GAGAAGCTGGGCGCTGGAGGGGACCTCACGGTGCTGAAC
CGTCGCCGGCTTCCTGATCCGCGCCGATCAACAAC
TTCACGGCTGAGCACCG
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Chemical Co. Ltd.), and amplified products were 
analyzed by electrophoresis through 2% agarose 
gels followed by ethidium bromide staining. 
In addition to electrophoretic detection, direct 
visualization of qepA1-positives in PMQR-positive 
strains (shown in Table 1) was performed by visual 
judgment using Loopamp fluorescent detection 
reagent (Eiken Chemical Co. Ltd.), according to the 
manufacturer’s instructions.
RESULTS
   The LAMP method was performed at 63℃ within 
one hour. This represents less than half the time 
required for standard PCR methods. Thereafter, the 
lowest detection level of qepA1 using this method 
was five copies of plasmid. 
   The LAMP method using a qepA1-specific LAMP 
primer set comprising five primers could detect all 
four qepA1-positive strains in addition to 17 qepA1-
negative strains (Table 1).
DISCUSSION
   In this study, we introduced a quick and easier 
detection method for the special qepA1 sequence 
in bacterial genomes using the LAMP method 
in combination with qepA1-targeted primer sets 
developed for this method. Our LAMP-based 
approach could detect qepA1-positive model strains, 
derived from PMQR gene-positive gram-negative 
rod characterized by a standard PCR method, 
with 100% sensitivity and specificity. Although 
the LAMP method requires DNA extraction, the 
total detection time is shorter than standard real-
time PCR. From our experiments, the application 
time was approximately one hour (plus time for 
DNA extraction), and represents less than half 
the time required for standard PCR or real-time 
PCR. Additionally, since standard PCR and real-
time PCR methods require special instrumentation, 
as well as special primer sets８－11）, the ultimate 
objective is to have available a simple, quick and 
accurate detection system that can be employed 
for routine examinations in clinical laboratories to 
detect qepA1 in clinically isolated bacteria. Thus, 
once the instrument and primer sets have been 
determined, factors such as time and accuracy need 
to be considered. From this standpoint, the LAMP 
method is clearly much more advantageous for 
use in clinical laboratories. Furthermore, the time 
and accuracy benefits allow for the selection of 
antibiotics in a clinical setting. 
   Although we should set most of the antibiotic-
resistant genes for clinical use, a better approach 
would be to strongly recommend use of the LAMP 
method for the detection of these genes to provide 
better support for the clinical selection of antibiotics 
to combat infections.
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